(Q47703868)

4 February 2018

title

Resistin and all-cause and cardiovascular mortality: effect modification by adiponectin in end-stage kidney disease patients (English)

1 reference

4 February 2018

author

Eric Sijbrands

3

1 reference

4 February 2018

Carmine Zoccali

8

1 reference

4 February 2018

Francesco U S Mattace-Raso

2

object named as

Francesco Mattace-Raso

1 reference

4 February 2018

author name string

Belinda Spoto

1

1 reference

4 February 2018

Patrizia Pizzini

4

1 reference

4 February 2018

Sebastiano Cutrupi

5

1 reference

4 February 2018

Graziella D'Arrigo

6

1 reference

4 February 2018

Giovanni Tripepi

7

1 reference

4 February 2018

Francesca Mallamaci

9

1 reference

4 February 2018

language of work or name

English

0 references

publication date

23 August 2013

1 reference

4 February 2018

Nephrology Dialysis Transplantation

published in

1 reference

4 February 2018

volume

28 Suppl 4

1 reference

4 February 2018

page(s)

iv181-7

1 reference

4 February 2018

Adiponectin in chronic kidney disease: a complex and context sensitive clinical situation

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

Comparative studies of resistin expression and phylogenomics in human and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

A family of tissue-specific resistin-like molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

An inflammatory cascade leading to hyperresistinemia in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

Resistin is an inflammatory marker of atherosclerosis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

Association of resistin with heart failure and mortality in patients with stable coronary heart disease: data from the heart and soul study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

Plasma adiponectin and resistin levels as predictors of mortality in patients with acute myocardial infarction: data from infarction prognosis study registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

Increased resistin blood levels are not associated with insulin resistance in patients with renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

Adipose tissue and its relation to inflammation: the role of adipokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

Associations between leptin and the leptin / adiponectin ratio and incident Type 2 diabetes in middle-aged men and women: results from the MONICA / KORA Augsburg Study 1984-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

Martingale difference residuals as a diagnostic tool for the Cox model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

The effect of joint exposures: examining the presence of interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT365

21 January 2018

Identifiers

DOI

10.1093/NDT/GFT365

1 reference

4 February 2018

1 reference

4 February 2018